<DOC>
	<DOCNO>NCT02006914</DOCNO>
	<brief_summary>This research investigate nutritional supplement chromium picolinate . The investigator test see effective supplement treat insulin resistance associate HIV disease .</brief_summary>
	<brief_title>Novel Therapy Glucose Intolerance HIV Disease</brief_title>
	<detailed_description>This study test hypothesis chromium picolinate improve insulin-stimulated glucose uptake increase insulin receptor-mediated tyrosine phosphorylation insulin receptor substrate-1 , result increase association phosphatidylinositol 3-kinase . Specific Aim 1 ass quantitative improvement insulin-mediated glucose disposal placebo-controlled clinical trial chromium supplementation 1000mpg ( 19.2 pmol ) chromium chromium picolinate , overa two-month course therapy . The investigator show insulin resistance ( i.e . inability insulin stimulate glucose uptake peripheral tissue like muscle ) patient HIV disease associate defect insulin-signaling pathway lead insulin receptor , phosphatidylinositol 3-kinase ( PI 3-K , Figure 5 ) . A similar defect intracellular signaling also report patient type 2 diabetes mellitus ) :15-171 . The cellular mechanism improve insulin sensitivity chromium supplementation determine Specific Aim 2 . Specific Aim 2 ass effect chromium supplementation insulin-stimulated activity insulin receptor substrate-I-associated phosphatidylinositol 3-kinase biopsy muscle fat tissue . This aim also test hypothesis physiological effect chromium mediate alteration activity insulin signal . Understanding mechanism may facilitate design even effective strategy improve insulin sensitivity .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Picolinic acid</mesh_term>
	<mesh_term>Chromium</mesh_term>
	<criteria>Age &gt; 18 year diagnosis HIV+ andlor AlDS make standard CDC criterion . 1. positive pregnancy test ( woman must negative pregnancy test begin protocol ) ; 2. diagnosis cancer ; 3. acute illness sort , however , patient may enrol stable ; 4. hemoglobin less 11.0 gldl hemodynamically unstable ; 5. creatinine great equal 1.5 mgldl ; 6. liver dysfunction evidence elevation transaminases 2fold high upper limit normal ; 7. use certain medication within past month ( e.g. , glucocorticoid ) . 8. untreated hypertension ( systolic BP &gt; 150 mmHG , diastolic BP &gt; 100 mmHG ) ; 9. patient diabetes mellitus 10. hypogonadism 11. abnormal thyroid function ( serum T ' 4 &lt; 4 &gt; 12 ; TSH &lt; 0.35 &gt; 5.5 ) 12. hepatitis C infection ( patient prior therapy stable evidence active infection include . This depend upon documentation primary care giver ) . 13 . CD4 count 300 14. viral load great 35,000 . Exclusion criterion ( 13 ) ( 14 ) add protocol require subject stable antiretroviral regime 3 month prior study 2 month study . These criterion make less likely antiretroviral therapy switch subject population well .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Insulin resistance</keyword>
	<keyword>HIV disease</keyword>
	<keyword>chromium picolinate</keyword>
</DOC>